Independent Power Producers
Compare Stocks
5 / 10Stock Comparison
KEN vs AMTD vs ITRN vs ESLT vs TEVA
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Communication Equipment
Aerospace & Defense
Drug Manufacturers - Specialty & Generic
KEN vs AMTD vs ITRN vs ESLT vs TEVA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Independent Power Producers | Asset Management | Communication Equipment | Aerospace & Defense | Drug Manufacturers - Specialty & Generic |
| Market Cap | $4.52B | $7M | $1.38B | $36.92B | $41.93B |
| Revenue (TTM) | $775M | $54M | $359M | $8.07B | $17.35B |
| Net Income (TTM) | $495M | $188M | $58M | $544M | $1.56B |
| Gross Margin | 17.1% | 45.2% | 49.7% | 24.4% | 52.1% |
| Operating Margin | 5.0% | 48.2% | 21.4% | 8.5% | 13.2% |
| Forward P/E | 7.6x | 0.3x | 17.8x | 57.3x | 14.5x |
| Total Debt | $1.28B | $283M | $5M | $965M | $17.38B |
| Cash & Equiv. | $1.02B | $63M | $108M | $635M | $3.56B |
KEN vs AMTD vs ITRN vs ESLT vs TEVA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Kenon Holdings Ltd. (KEN) | 100 | 422.8 | +322.8% |
| AMTD IDEA Group (AMTD) | 100 | 2.7 | -97.3% |
| Ituran Location and… (ITRN) | 100 | 344.5 | +244.5% |
| Elbit Systems Ltd. (ESLT) | 100 | 564.2 | +464.2% |
| Teva Pharmaceutical… (TEVA) | 100 | 287.4 | +187.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: KEN vs AMTD vs ITRN vs ESLT vs TEVA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
KEN is the #2 pick in this set and the best alternative if momentum is your priority.
- +194.0% vs AMTD's +5.0%
AMTD carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.06, yield 36.7%
- Lower volatility, beta 0.06, Low D/E 16.7%, current ratio 10.62x
- Beta 0.06, yield 36.7%, current ratio 10.62x
- Lower P/E (0.3x vs 14.5x)
ITRN ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.58 vs ESLT's 3.48
- 15.8% ROA vs TEVA's 3.9%, ROIC 47.2% vs 7.7%
ESLT is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 23.9%, EPS growth 71.7%, 3Y rev CAGR 17.8%
- 7.4% 10Y total return vs KEN's 12.6%
- 23.9% revenue growth vs AMTD's -55.9%
Among these 5 stocks, TEVA doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.9% revenue growth vs AMTD's -55.9% | |
| Value | Lower P/E (0.3x vs 14.5x) | |
| Quality / Margins | 94.4% margin vs ESLT's 6.7% | |
| Stability / Safety | Beta 0.06 vs ITRN's 1.18 | |
| Dividends | 36.7% yield, 1-year raise streak, vs ITRN's 3.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +194.0% vs AMTD's +5.0% | |
| Efficiency (ROA) | 15.8% ROA vs TEVA's 3.9%, ROIC 47.2% vs 7.7% |
KEN vs AMTD vs ITRN vs ESLT vs TEVA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
KEN vs AMTD vs ITRN vs ESLT vs TEVA — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMTD leads in 2 of 6 categories
ITRN leads 1 • ESLT leads 1 • KEN leads 0 • TEVA leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AMTD leads this category, winning 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TEVA is the larger business by revenue, generating $17.3B annually — 320.9x AMTD's $54M. AMTD is the more profitable business, keeping 94.4% of every revenue dollar as net income compared to ESLT's 6.7%. On growth, ITRN holds the edge at +12.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $775M | $54M | $359M | $8.1B | $17.3B |
| EBITDAEarnings before interest/tax | $122M | $263M | $96M | $857M | $3.3B |
| Net IncomeAfter-tax profit | $495M | $188M | $58M | $544M | $1.6B |
| Free Cash FlowCash after capex | $222M | $45M | $71M | $564M | $1.2B |
| Gross MarginGross profit ÷ Revenue | +17.1% | +45.2% | +49.7% | +24.4% | +52.1% |
| Operating MarginEBIT ÷ Revenue | +5.0% | +48.2% | +21.4% | +8.5% | +13.2% |
| Net MarginNet income ÷ Revenue | +63.8% | +94.4% | +16.1% | +6.7% | +9.0% |
| FCF MarginFCF ÷ Revenue | +28.6% | +9.5% | +19.7% | +7.0% | +6.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.3% | — | +12.8% | +11.8% | +2.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -95.3% | -88.3% | +10.0% | +79.5% | +72.2% |
Valuation Metrics
AMTD leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 0.3x trailing earnings, AMTD trades at a 100% valuation discount to ESLT's 64.5x P/E. Adjusting for growth (PEG ratio), ITRN offers better value at 0.66x vs ESLT's 3.92x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.5B | $7M | $1.4B | $36.9B | $41.9B |
| Enterprise ValueMkt cap + debt − cash | $4.8B | $228M | $1.3B | $37.2B | $55.8B |
| Trailing P/EPrice ÷ TTM EPS | 7.64x | 0.25x | 20.19x | 64.47x | 30.01x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 17.84x | 57.26x | 14.55x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.66x | 3.92x | — |
| EV / EBITDAEnterprise value multiple | 33.93x | 6.93x | 13.33x | 39.55x | 17.65x |
| Price / SalesMarket cap ÷ Revenue | 6.01x | 0.14x | 3.85x | 4.30x | 2.43x |
| Price / BookPrice ÷ Book value/share | 1.72x | 0.01x | 5.22x | 9.03x | 5.34x |
| Price / FCFMarket cap ÷ FCF | — | 1.44x | 20.72x | 61.70x | 36.52x |
Profitability & Efficiency
ITRN leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
ITRN delivers a 27.3% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $13 for AMTD. ITRN carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to TEVA's 2.20x. On the Piotroski fundamental quality scale (0–9), KEN scores 8/9 vs AMTD's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +19.1% | +12.9% | +27.3% | +14.1% | +20.7% |
| ROA (TTM)Return on assets | +11.4% | +10.8% | +15.8% | +4.5% | +3.9% |
| ROICReturn on invested capital | +1.2% | +1.2% | +47.2% | +12.8% | +7.7% |
| ROCEReturn on capital employed | +1.2% | +1.6% | +29.5% | +12.2% | +8.0% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 3 | 7 | 8 | 8 |
| Debt / EquityFinancial leverage | 0.48x | 0.17x | 0.02x | 0.23x | 2.20x |
| Net DebtTotal debt minus cash | $264M | $221M | -$103M | $330M | $13.8B |
| Cash & Equiv.Liquid assets | $1.0B | $63M | $108M | $635M | $3.6B |
| Total DebtShort + long-term debt | $1.3B | $283M | $5M | $965M | $17.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.52x | 17.18x | 32.28x | 4.92x | 2.51x |
Total Returns (Dividends Reinvested)
ESLT leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ESLT five years ago would be worth $58,629 today (with dividends reinvested), compared to $256 for AMTD. Over the past 12 months, KEN leads with a +194.0% total return vs AMTD's +5.0%. The 3-year compound annual growth rate (CAGR) favors ESLT at 61.1% vs AMTD's -40.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +34.0% | +2.9% | +42.2% | +34.5% | +16.3% |
| 1-Year ReturnPast 12 months | +194.0% | +5.0% | +76.7% | +92.7% | +104.6% |
| 3-Year ReturnCumulative with dividends | +246.9% | -78.8% | +206.4% | +318.0% | +297.5% |
| 5-Year ReturnCumulative with dividends | +240.6% | -97.4% | +180.2% | +486.3% | +246.2% |
| 10-Year ReturnCumulative with dividends | +1256.7% | -91.4% | +233.6% | +737.2% | -28.3% |
| CAGR (3Y)Annualised 3-year return | +51.4% | -40.4% | +45.2% | +61.1% | +58.4% |
Risk & Volatility
Evenly matched — AMTD and ITRN each lead in 1 of 2 comparable metrics.
Risk & Volatility
AMTD is the less volatile stock with a 0.06 beta — it tends to amplify market swings less than ITRN's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ITRN currently trades 98.5% from its 52-week high vs AMTD's 63.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.90x | 0.06x | 1.18x | 0.35x | 1.13x |
| 52-Week HighHighest price in past year | $95.93 | $1.65 | $59.84 | $1016.00 | $37.35 |
| 52-Week LowLowest price in past year | $30.42 | $0.87 | $32.71 | $369.60 | $14.99 |
| % of 52W HighCurrent price vs 52-week peak | +90.3% | +63.6% | +98.5% | +78.2% | +96.4% |
| RSI (14)Momentum oscillator 0–100 | 60.3 | 48.3 | 68.3 | 43.6 | 73.5 |
| Avg Volume (50D)Average daily shares traded | 26K | 24K | 118K | 165K | 6.6M |
Analyst Outlook
Evenly matched — AMTD and ITRN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: KEN as "Hold", ITRN as "Hold", ESLT as "Hold", TEVA as "Buy". Consensus price targets imply 8.3% upside for TEVA (target: $39) vs -33.2% for ESLT (target: $531). For income investors, AMTD offers the higher dividend yield at 36.70% vs ESLT's 0.32%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | — | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | — | $56.00 | $531.00 | $39.00 |
| # AnalystsCovering analysts | 1 | — | 5 | 6 | 46 |
| Dividend YieldAnnual dividend ÷ price | +4.4% | +36.7% | +3.2% | +0.3% | — |
| Dividend StreakConsecutive years of raises | 1 | 1 | 3 | 1 | 1 |
| Dividend / ShareAnnual DPS | $3.80 | $0.39 | $1.89 | $2.58 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | 0.0% | +0.2% | 0.0% | 0.0% |
AMTD leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). ITRN leads in 1 (Profitability & Efficiency). 2 tied.
KEN vs AMTD vs ITRN vs ESLT vs TEVA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is KEN or AMTD or ITRN or ESLT or TEVA a better buy right now?
For growth investors, Elbit Systems Ltd.
(ESLT) is the stronger pick with 23. 9% revenue growth year-over-year, versus -55. 9% for AMTD IDEA Group (AMTD). AMTD IDEA Group (AMTD) offers the better valuation at 0. 3x trailing P/E, making it the more compelling value choice. Analysts rate Teva Pharmaceutical Industries Limited (TEVA) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — KEN or AMTD or ITRN or ESLT or TEVA?
On trailing P/E, AMTD IDEA Group (AMTD) is the cheapest at 0.
3x versus Elbit Systems Ltd. at 64. 5x. On forward P/E, Teva Pharmaceutical Industries Limited is actually cheaper at 14. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Ituran Location and Control Ltd. wins at 0. 58x versus Elbit Systems Ltd. 's 3. 48x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — KEN or AMTD or ITRN or ESLT or TEVA?
Over the past 5 years, Elbit Systems Ltd.
(ESLT) delivered a total return of +486. 3%, compared to -97. 4% for AMTD IDEA Group (AMTD). Over 10 years, the gap is even starker: KEN returned +1257% versus AMTD's -91. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — KEN or AMTD or ITRN or ESLT or TEVA?
By beta (market sensitivity over 5 years), AMTD IDEA Group (AMTD) is the lower-risk stock at 0.
06β versus Ituran Location and Control Ltd. 's 1. 18β — meaning ITRN is approximately 1761% more volatile than AMTD relative to the S&P 500. On balance sheet safety, Ituran Location and Control Ltd. (ITRN) carries a lower debt/equity ratio of 2% versus 2% for Teva Pharmaceutical Industries Limited — giving it more financial flexibility in a downturn.
05Which is growing faster — KEN or AMTD or ITRN or ESLT or TEVA?
By revenue growth (latest reported year), Elbit Systems Ltd.
(ESLT) is pulling ahead at 23. 9% versus -55. 9% for AMTD IDEA Group (AMTD). On earnings-per-share growth, the picture is similar: Kenon Holdings Ltd. grew EPS 356. 6% year-over-year, compared to -68. 5% for AMTD IDEA Group. Over a 3-year CAGR, ESLT leads at 17. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — KEN or AMTD or ITRN or ESLT or TEVA?
AMTD IDEA Group (AMTD) is the more profitable company, earning 94.
4% net margin versus 6. 7% for Elbit Systems Ltd. — meaning it keeps 94. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMTD leads at 48. 2% versus 6. 3% for KEN. At the gross margin level — before operating expenses — TEVA leads at 51. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is KEN or AMTD or ITRN or ESLT or TEVA more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Ituran Location and Control Ltd. (ITRN) is the more undervalued stock at a PEG of 0. 58x versus Elbit Systems Ltd. 's 3. 48x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Teva Pharmaceutical Industries Limited (TEVA) trades at 14. 5x forward P/E versus 57. 3x for Elbit Systems Ltd. — 42. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TEVA: 8. 3% to $39. 00.
08Which pays a better dividend — KEN or AMTD or ITRN or ESLT or TEVA?
In this comparison, AMTD (36.
7% yield), KEN (4. 4% yield), ITRN (3. 2% yield), ESLT (0. 3% yield) pay a dividend. TEVA does not pay a meaningful dividend and should not be held primarily for income.
09Is KEN or AMTD or ITRN or ESLT or TEVA better for a retirement portfolio?
For long-horizon retirement investors, Kenon Holdings Ltd.
(KEN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 90), 4. 4% yield, +1257% 10Y return). Both have compounded well over 10 years (KEN: +1257%, TEVA: -28. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between KEN and AMTD and ITRN and ESLT and TEVA?
These companies operate in different sectors (KEN (Utilities) and AMTD (Financial Services) and ITRN (Technology) and ESLT (Industrials) and TEVA (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: KEN is a small-cap deep-value stock; AMTD is a small-cap deep-value stock; ITRN is a small-cap income-oriented stock; ESLT is a mid-cap high-growth stock; TEVA is a mid-cap quality compounder stock. KEN, AMTD, ITRN pay a dividend while ESLT, TEVA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.